The waist to hip ratio should be less than 1.0 to lower the health risk in adults. Kids are at a higher health risk if the ratio is more than 0.9. Dr. Fals (Pediatrician at Florida Hospital for Children) and researcher Lindy Moore (Exercise Physiology Manager) are studying a non-invasive way to accurately predict the risk of diabetes in the children.
The researchers have found a hormone for the treatment of type 2 diabetes (T2D). The researchers are from the Norwegian University of Science and Technology (NTNU) and Oxford University.
The researchers say that the gastric bypass surgery is the most effective treatment for weight loss. The surgery causes a lower blood sugar (glucose) levels and an improvement in the other risk factors of diabetes.
The researchers believed that the remission of type 2 diabetes after the gastric bypass surgery is due to the increase in the production of the GLP-1 hormone, which causes a lower appetite.
But the researchers have found that the PYY hormone can lower the appetite. Now, the researchers are planning to develop a treatment to stimulate the PYY hormone to control the appetite and the risk of type 2 diabetes (T2D).
The National Microbiome Initiative (NMI) programme was launched by the White House to know more about the microbiomes. The healthy microbiomes can help the process industries and also in maintaining the ecological balance, agricultural production and can keep us healthy.
The Bill and Melinda Gates Foundation is funding the research on the human and agricultural microbiomes. The Juvenile Diabetes Research Foundation is funding another study to find out the association between the microbiomes and the risk of type 1 diabetes (T1D).
The InDependent Diabetes Trust (IDDT), an international charity based at Northampton has distributed a free booklet for the schools. The pdf document contains information and tips about diabetes to educate the students.
Prof. Damien Keating, a professor at the Flinders University, Australia and his team have found a single gene called RCAN1. Researchers say that the RCAN1 gene may cause the defects in the insulin secretion and can play a role in the onset of type 2 diabetes. The gene may also play a role in the down syndrome.
The current drugs for the treatment of diabetes are focusing more on managing the disease and not to prevent the causes of the disease (such as RCAN1 gene). Scientists say that no one knows what causes a change in the pancreatic islets and those changes can trigger an enhanced risk of type 2 diabetes (T2D).
Type 2 diabetes (T2D) is a complex metabolic disease caused due to the dysfunction of the beta cell. The study was published in the journal PLOS Genetics.
Tandem Diabetes Care, Inc. is a medical devices company. The company deals with the products for insulin-dependent patients with diabetes.
The insulin pump products are slim Insulin Delivery System, Flex Insulin Delivery System and Slim G4 Insulin Delivery System. The products are using the Micro-Delivery Technology to draw the insulin from a flexible bag within the pump.
The Institute of Diabetes Research has published the first Fr1da study in the BMJ Open journal. This study was started in Feb 2015. This study was intended to find out the causes of early onset of type 1 diabetes by examining the autoantibodies of the pancreatic beta cell in the blood.
The Bavarian pilot project Fr1da study can help in finding the treatment for the diabetic ketoacidosis (DKA). DKA is the body condition with a high blood sugar (glucose) levels and insufficient insulin. When it happens, there would be a breakdown in the fat molecules for the production of energy in the cell and the deposits of ketones in the blood and urine.
If a person is at an early risk of type 1 diabetes (T1D) and if it is asymptomatic, then there is a possibility of the life-threatening metabolic imbalance (ketoacidosis).
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.